Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETAP: Tocilizumab in Primary Sjögren's Syndrome
NCT01782235Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jul 2013
- Primary completion
- Jul 2018
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in primary Sjögren's syndrome, sponsored by Strasbourg University Hospital. Started Jul 2013; status: completed.
02
Drugs
tocilizumab
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT01782235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782235.